Patrick J Smith1, James A Blumenthal2, Robert M Carney3, Kenneth E Freedland3, C Virginia F O'Hayer4, Elbert P Trulock5, Tereza Martinu6, Todd A Schwartz4, Benson M Hoffman2, Gary G Koch4, R Duane Davis7, Scott M Palmer6. 1. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Duke University Health System, Durham, NC. Electronic address: patrick.j.smith@dm.duke.edu. 2. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Duke University Health System, Durham, NC. 3. Washington University School of Medicine in St. Louis, St. Louis, MO. 4. College of Medicine, Drexel University, Philadelphia, PA. 5. Washington University School of Medicine in St. Louis, St. Louis, MO; Department of Biostatistics, UNC Gillings School of Global Public Health, Chapel Hill, NC. 6. Department of Medicine, Duke University Medical Center, Duke University Health System, Durham, NC. 7. Department of Surgery, Duke University Medical Center, Duke University Health System, Durham, NC.
Abstract
BACKGROUND:Neurobehavioral functioning is widely recognized as being an important consideration in lung transplant candidates, but little is known about whether these factors are related to clinical outcomes. The present study examined the relationship of neurobehavioral functioning, including measures of executive function and memory, depression, and anxiety, to long-term survival among lung transplant recipients. METHODS: The sample was drawn from 201 patients who underwent transplantation at Duke University and Washington University who participated in a dual-site clinical trial investigating medical and psychosocial outcomes in transplant candidates with end-stage lung disease. All patients completed the Beck Depression Inventory-II (BDI-II) and Spielberger State-Trait Anxiety Inventory at baseline and again after 12 weeks, while a subset of 86 patients from Duke University also completed neurocognitive testing. Patients were followed for survival up to 12 years after completing baseline assessments. RESULTS:One hundred eleven patients died over a mean follow-up of 10.8 years (SD=0.8). Baseline depression, anxiety, and neurocognitive function were examined as predictors of posttransplant survival, controlling for age, 6-min walk distance, FEV, and native disease; education and cardiovascular risk factors were also included in the model for neurocognition. Lower executive function (hazard ratio [HR]=1.09, P=.012) and memory performance (HR=1.11, P=.030) were independently associated with greater mortality following lung transplant. Although pretransplant depression and anxiety were not predictive of mortality, patients who scored>13 on the BDI-II at baseline and after 3 months pretransplant had greater mortality (HR=1.85 [95% CI, 1.04, 3.28], P=.036). CONCLUSIONS:Neurobehavioral functioning, including persistently elevated depressive symptoms and lower neurocognitive performance, was associated with reduced survival after lung transplantation. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00113139; URL: www.clinicaltrials.gov.
RCT Entities:
BACKGROUND: Neurobehavioral functioning is widely recognized as being an important consideration in lung transplant candidates, but little is known about whether these factors are related to clinical outcomes. The present study examined the relationship of neurobehavioral functioning, including measures of executive function and memory, depression, and anxiety, to long-term survival among lung transplant recipients. METHODS: The sample was drawn from 201 patients who underwent transplantation at Duke University and Washington University who participated in a dual-site clinical trial investigating medical and psychosocial outcomes in transplant candidates with end-stage lung disease. All patients completed the Beck Depression Inventory-II (BDI-II) and Spielberger State-Trait Anxiety Inventory at baseline and again after 12 weeks, while a subset of 86 patients from Duke University also completed neurocognitive testing. Patients were followed for survival up to 12 years after completing baseline assessments. RESULTS: One hundred eleven patients died over a mean follow-up of 10.8 years (SD=0.8). Baseline depression, anxiety, and neurocognitive function were examined as predictors of posttransplant survival, controlling for age, 6-min walk distance, FEV, and native disease; education and cardiovascular risk factors were also included in the model for neurocognition. Lower executive function (hazard ratio [HR]=1.09, P=.012) and memory performance (HR=1.11, P=.030) were independently associated with greater mortality following lung transplant. Although pretransplant depression and anxiety were not predictive of mortality, patients who scored>13 on the BDI-II at baseline and after 3 months pretransplant had greater mortality (HR=1.85 [95% CI, 1.04, 3.28], P=.036). CONCLUSIONS: Neurobehavioral functioning, including persistently elevated depressive symptoms and lower neurocognitive performance, was associated with reduced survival after lung transplantation. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT00113139; URL: www.clinicaltrials.gov.
Authors: Priti I Parekh; James A Blumenthal; Michael A Babyak; Rick LaCaille; Sarah Rowe; Liz Dancel; Robert M Carney; R Duane Davis; Scott Palmer Journal: Psychosom Med Date: 2005 May-Jun Impact factor: 4.312
Authors: H C Squier; A L Ries; R M Kaplan; L M Prewitt; C M Smith; J M Kriett; S W Jamieson Journal: Am J Respir Crit Care Med Date: 1995-12 Impact factor: 21.405
Authors: James A Blumenthal; Heather S Lett; Michael A Babyak; William White; Peter K Smith; Daniel B Mark; Robert Jones; Joseph P Mathew; Mark F Newman Journal: Lancet Date: 2003-08-23 Impact factor: 79.321
Authors: Priti I Parekh; James A Blumenthal; Michael A Babyak; Kari Merrill; Robert M Carney; R Duane Davis; Scott M Palmer Journal: Chest Date: 2003-11 Impact factor: 9.410
Authors: T Martinu; M A Babyak; C F O'Connell; R M Carney; E P Trulock; R D Davis; J A Blumenthal; S M Palmer Journal: Am J Transplant Date: 2008-07 Impact factor: 8.086
Authors: Annette De Vito Dabbs; Mary Amanda Dew; Carol S Stilley; Jan Manzetti; Thomas Zullo; Kenneth R McCurry; Robert L Kormos; Aldo Iacono Journal: J Heart Lung Transplant Date: 2003-11 Impact factor: 10.247
Authors: Emily M Rosenberger; Andrea F DiMartini; Annette J DeVito Dabbs; Christian A Bermudez; Joseph M Pilewski; Yoshiya Toyoda; Mary Amanda Dew Journal: Transplantation Date: 2016-01 Impact factor: 4.939
Authors: Kathleen J Ramos; Patrick J Smith; Edward F McKone; Joseph M Pilewski; Amy Lucy; Sarah E Hempstead; Erin Tallarico; Albert Faro; Daniel B Rosenbluth; Alice L Gray; Jordan M Dunitz Journal: J Cyst Fibros Date: 2019-03-27 Impact factor: 5.482
Authors: J P Singer; P P Katz; A Soong; P Shrestha; D Huang; J Ho; M Mindo; J R Greenland; S R Hays; J Golden; J Kukreja; M E Kleinhenz; R J Shah; P D Blanc Journal: Am J Transplant Date: 2017-01-03 Impact factor: 8.086
Authors: Jonathan P Singer; Joshua M Diamond; Michaela R Anderson; Patricia P Katz; Ken Covinsky; Michelle Oyster; Tatiana Blue; Allison Soong; Laurel Kalman; Pavan Shrestha; Selim M Arcasoy; John R Greenland; Lori Shah; Jasleen Kukreja; Nancy P Blumenthal; Imaani Easthausen; Jeffrey A Golden; Amika McBurnie; Ed Cantu; Joshua Sonett; Steven Hays; Hilary Robbins; Kashif Raza; Matthew Bacchetta; Rupal J Shah; Frank D'Ovidio; Aida Venado; Jason D Christie; David J Lederer Journal: Am J Transplant Date: 2018-05-14 Impact factor: 8.086
Authors: Patrick J Smith; Sara Rivelli; Alexa Waters; John Reynolds; Amelia Hoyle; Miranda Flowers; R D Davis; Scott M Palmer; Joseph Mathew; Michael Durheim; James A Blumenthal Journal: Ann Am Thorac Soc Date: 2014-12
Authors: Nicholas A Kolaitis; Allison Soong; Pavan Shrestha; Hanjing Zhuo; John Neuhaus; Patti P Katz; John R Greenland; Jeffrey Golden; Lorriana E Leard; Rupal J Shah; Steven R Hays; Jasleen Kukreja; Mary Ellen Kleinhenz; Paul D Blanc; Jonathan P Singer Journal: J Thorac Cardiovasc Surg Date: 2018-02-22 Impact factor: 5.209
Authors: Mary Amanda Dew; Emily M Rosenberger; Larissa Myaskovsky; Andrea F DiMartini; Annette J DeVito Dabbs; Donna M Posluszny; Jennifer Steel; Galen E Switzer; Diana A Shellmer; Joel B Greenhouse Journal: Transplantation Date: 2015-05 Impact factor: 4.939
Authors: P J Smith; J A Blumenthal; E P Trulock; K E Freedland; R M Carney; R D Davis; B M Hoffman; S M Palmer Journal: Am J Transplant Date: 2015-09-14 Impact factor: 8.086